Protocol for generation of human peptide-specific primary CD8+ T cell lines

[1]  C. Szeto,et al.  CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses , 2021, Immunity.

[2]  C. Szeto,et al.  The presentation of SARS-CoV-2 peptides by the common HLA-A∗02:01 molecule , 2021, iScience.

[3]  S. Tangye,et al.  CD8+ T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph , 2020, Nature Communications.

[4]  L. Loh,et al.  HLA-B*27:05 alters immunodominance hierarchy of universal influenza-specific CD8+ T cells , 2020, PLoS pathogens.

[5]  David F. Boyd,et al.  Human CD8+ T cell cross-reactivity across influenza A, B and C viruses , 2019, Nature Immunology.

[6]  L. Loh,et al.  Broad CD8+ T cell cross-recognition of distinct influenza A strains in humans , 2018, Nature Communications.

[7]  M. Hellard,et al.  Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct αβT Cell Receptor Signatures* , 2016, The Journal of Biological Chemistry.

[8]  L. Loh,et al.  Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities , 2014, Proceedings of the National Academy of Sciences.

[9]  K. Kedzierska,et al.  Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T‐cell responses , 2013, Immunology and cell biology.

[10]  P. Doherty,et al.  Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals , 2011, Proceedings of the National Academy of Sciences.